Literature DB >> 15503347

Relationship between vertebral bone marrow blood perfusion and common carotid intima-media thickness in aging adults.

Wei-Tsung Chen1, Tiffany Ting-Fang Shih, Chaur-Jong Hu, Ran-Chou Chen, Hsing-Yang Tu.   

Abstract

PURPOSE: To evaluate the relationship between vertebral marrow blood perfusion and common carotid intima-media thickness (IMT) in aging adults.
MATERIALS AND METHODS: An age- and sex-matched case control study was conducted. Subjects were contacted and enrolled voluntarily according to a database containing 2,258 cases that received carotid ultrasonography examination at our hospital in the previous two years. Forty-three pairs of subjects (56 male, 30 female; aged 44-85 years, average 63 years) underwent dynamic contrast-enhanced magnetic resonance (MR) study of the lumbar spine. The average peak enhancement percentage of the second to fourth lumbar vertebrae was used to represent the vertebral marrow perfusion status for each subject. The common carotid IMT, presence of plaque, peak enhancement percentage, body mass index (BMI), systolic and diastolic blood pressure, serum total cholesterol, high-density lipoprotein (HDL), and triglycerol levels were acquired for statistical analysis.
RESULTS: The average peak enhancement percentage was significantly lower in thickened IMT group compared to the normal IMT group (73 +/- 23 vs. 90 +/- 27, P=0.0023). The carotid IMT inversely correlated with vertebral peak enhancement percentage (r=-0.33, P=0.0018). The vertebral peak enhancement percentage was significantly lower in subjects with presence of any carotid plaque (P=0.032). Common carotid IMT was the only significant variable that was negatively associated with vertebral marrow perfusion after adjusting for the effect of sex, age, blood pressure, BMI, total cholesterol, HDL, and triglycerol level in linear regression model (P=0.008).
CONCLUSION: Our data demonstrate the negative association between vertebral marrow blood perfusion and common carotid IMT. These results suggest that common carotid IMT may provide the information of tissue perfusion status of the vertebral bone marrow.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15503347     DOI: 10.1002/jmri.20187

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  Hard arteries, weak bones.

Authors:  James F Griffith; S M Kumta; Yu Huang
Journal:  Skeletal Radiol       Date:  2011-05       Impact factor: 2.199

2.  The associations of subclinical atherosclerotic cardiovascular disease with hip fracture risk and bone mineral density in elderly adults.

Authors:  J I Barzilay; P Buzkova; J A Cauley; J A Robbins; H A Fink; K J Mukamal
Journal:  Osteoporos Int       Date:  2018-08-21       Impact factor: 4.507

3.  Dynamic contrast enhanced magnetic resonance imaging of diffuse spinal bone marrow infiltration in patients with hematological malignancies.

Authors:  Yunfei Zha; Maojin Li; Jianyong Yang
Journal:  Korean J Radiol       Date:  2010-02-22       Impact factor: 3.500

4.  Bone mineral density and atherosclerosis: the Multi-Ethnic Study of Atherosclerosis, Abdominal Aortic Calcium Study.

Authors:  Joseph A Hyder; Matthew A Allison; Elizabeth Barrett-Connor; Robert Detrano; Nathan D Wong; Claude Sirlin; Susan M Gapstur; Pamela Ouyang; J Jeffrey Carr; Michael H Criqui
Journal:  Atherosclerosis       Date:  2009-09-12       Impact factor: 5.162

5.  Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study.

Authors:  Joseph A Hyder; Matthew A Allison; Nathan Wong; Agnes Papa; Thomas F Lang; Claude Sirlin; Susan M Gapstur; Pamela Ouyang; J Jeffrey Carr; Michael H Criqui
Journal:  Am J Epidemiol       Date:  2008-12-08       Impact factor: 4.897

6.  A study of dynamic contrast-enhanced MR imaging features and influence factors of pelvic bone marrow in adult females.

Authors:  X Zhang; H Pang; Y Dong; D Shi; F Liu; Y Luo; T Yu; X Wang
Journal:  Osteoporos Int       Date:  2019-08-26       Impact factor: 4.507

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.